ISTH 2020 Congress

Platelet Disorders and von Willebrand Disease » Antiplatelet Therapy

Theme Navigation

ISTH 2020 Congress
- Platelet Disorders and von Willebrand Disease
  - Antiplatelet Therapy

Abstract Number: PB1408

Assessment of the Hemostatic System by Total Thrombus-formation Analysis System (T-TAS) in Patients with Chronic Coronary Syndromes

O. Sirotkina^1,2, I. Nazarova¹, O. Melnichnikova¹, A. Panov¹, T. Vavilova¹

Abstract Number: PB1404

Circulating Myeloid-related Protein (MRP)-8/14 May Contribute to Suboptimal Response to Low Dose Aspirin in Patients with Type 2 Diabetes mellitus

P.G.M. Simeone, R. Tripaldi, R. Liani, S. Ciotti, A. Boccatonda, D. D'Ardes, F. Santilli

Abstract Number: PB1395

Comparison of Platelet Function Testing in Patients Undergoing Neuroradiological Flow Diversion Stents

M. Gergi¹, R. McTaggart², T. Cheves³, J. Sweeney⁴

Abstract Number: PB1406

Correlation of VASP Phosphorylation Assay with Light Transmission Aggregometry for Patients Treated with Clopidogrel or Ticagrelor

C. Pons¹, M. Moulard¹, M. Canault², M. Ibrahim², M.-C. Alessi²

Abstract Number: PB1390

Desmopressin for Reversal of Antiplatelet Drugs in Stroke due to Haemorrhage (DASH): Interim Report on Recruitment from a Phase II Double Blind Randomised Controlled Trial

M. Desborough¹, R. Al-Shahi Salman², S. Stanworth^3,4, D. Havard⁵, P.M. Brennan², R. Dineen⁵, T. Coats⁶, P. Johnson⁷, T. Hepburn⁸, P. Bath⁵, N. Sprigg⁵, DASH Trial Investigators

Abstract Number: PB1393

Detection of Clopidogrel Resistance: Comparison of Light Transmission Aggregometry and INNOVANCE® PFA P2Y Cartridge and Correlation with CYP2C19 Variants

L. Heireman, K. Devreese

Abstract Number: PB1402

Discontinuation of Chronic Low Dose Acetylsalicylic Acid Therapy Upon Intensive Care Medicine Department Admission Appears to Increase Mortality

F. Martins Pereira¹, S. Abreu², P. Mergulhão^3,4, J.A. Paiva^4,5,6

Abstract Number: PB1392

Efficacy of Antiplatelet Therapy in Patients with Acute Ischemic Stroke Treated with Acetylsalicylic Acid

L. Bultasova¹, Z. Hajsmanova¹, P. Sigutova¹, V. Rohan², J. Polivka²

Abstract Number: PB1398

Evaluation of Dual Antiplatelet Therapy Combining Aspirin and Clopidogrel for Intracranial Stenting Procedures: A Retrospective Single Center Study

L. Goncalves, D. Goncalves, C. Monteiro, C. Koch

Abstract Number: PB1403

Evaluation of Platelet Reactivity in Pediatric Patient on Dual Antiplatelet Therapy after Stent Implantation of Ductus Arteriosus: A Case Report

D. Dineva¹, E. Doncheva¹, E. Levunlieva²

Abstract Number: PB1407

Intra-individual Residual Platelet Reactivity upon Antiplatelet Therapy in the Perioperative Period Significantly Differs over Time – What Is the Ideal Moment to Monitor Efficacy of Antiplatelet Therapy in Vascular Patients?

N.C. Roozendaal¹, A.R.T. Brand¹, R.T. Urbanus², G.J. De Borst¹, S. Korporaal³

Abstract Number: PB1387

Long-term Variation of Platelet Reactivity in High-Risk Patients on Antiplatelet Therapy after Percutaneous Coronary Intervention

R. Olie^1,2, J. Roelofs¹, L. Veenstra³, Y. Henskens⁴, M. Vries², P.E.J. van der Meijden², H. ten Cate^1,2

Abstract Number: PB1391

Lysine-Containing Peptides as Promising Antiplatelet Drugs

M. Grigorjeva, L. Lyapina

Abstract Number: PB1384

Platelet Function Assay PFA-200 for Monitoring of Antiplatelet Drug Effect

T. Makarovska Bojadjieva¹, S. Useini², E. Velkova², E. Todorovska², J. Nikolova², E. Ristovska², E. Petkovik², R. Grubovic²

Abstract Number: PB1394

Potent platelet inhibition results in improved long-term clinical outcome independent from clinical variables

G. Gager¹, B. Jilma¹, M.-P. Winter², C. Hengstenberg³, I. Lang³, A. Toma³, F. Prüller⁴, M. Wallner⁴, E. Kolesnik⁴, D. von Lewinski⁴, J. Siller-Matula³

Abstract Number: PB1388

Synthesis of Antiplatelet Ortho-Carbonyl Hydroquinones: A Spiro Derivative is Selective against Collagen-Stimulated Platelets

E. Fuentes¹, D. Mendez¹, F. Urra², J.P. Millas-Vargas¹, M. Alarcón¹, I. Palomo¹, R. Araya-Maturana¹

Abstract Number: PB1389

The Effect of Aspirin in Tumor Growth of Obese Mice Involving Inhibition of Metabolism

J.-D. Wang¹, C.-J. Chen², W.-Y. Chen³, J.-R. Li⁴, S.-Y. Lin⁴, Y.-Y. Wang⁵

Abstract Number: PB1401

The Effect of Plasma Fibrinogen Level on Predictive Value of VerifyNow P2Y12 Assay Results in Patients Undergoing Percutaneous Coronary Interventions

A. Dobrovolsky¹, P. Laguta¹, E. Titaeva¹, A. Komarov¹, E. Novikova¹, E. Guskova¹, E. Yarovaya², E. Panchenko¹

Abstract Number: PB1397

Ticagrelor Mechanism of Action on Gram-Positive Bacteria

L. Musumeci¹, N. Jacques¹, N. Penoy², G. Piel², E. Goffin², B. Pirotte², A.M. Amoroso³, B. Joris³, O. Verlaine³, P. Lancellotti^1,4, C. Oury¹

« View all themes from the ISTH 2020 Congress